Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Mabthera(R) (Rituximab) Available On NHS For UK's Most Common Leukaemia
The National Institute for Health and Clinical Excellence (NICE) today issued its recommendation for the use of MabThera® (rituximab) in the UK"s most common form of leukaemia, chronic lymphocytic leukaemia (CLL).1,2,3 NICE"s final guidance recommends rituximab in combination with fludarabine and cyclophosphamide (FC) chemotherapy as an option for previously untreated patients with CLL.4 The addition of rituximab to FC chemotherapy has been proven to halt progression of the disease by 10.5 months longer than chemotherapy alone, and more than doubles the number of CLL patients achieving complete remission, compared to chemotherapy.5,6 More than 20,000 people in the UK are living with CLL and there are an estimated 3,700 new cases every year.7,8 Professor John Gribben, Consultant Haematologist and Medical Oncologist, Barts and The London NHS Trust, commented:
generic viagra online
General Medical Council Announces Launch Date For Doctors' Licences, UK
The GMC has announced the launch date of a milestone in medical regulation. From 16 November, all doctors will need a licence in order to practise medicine in the UK.
News of the day
Legislation Introduced To Tackle California's GPCI Problem, Raise Medicare Rates In Certain High-Cost Counties
U.S. Rep. Sam Farr (D-Calif.) and Sen. Dianne Feinstein (D-Calif.) introduced legislation sponsored by the California Medical Association to eliminate one of the biggest barriers for seniors to get access to health care - low Medicare reimbursement rates in several counties.
Endocrinology

Women's Way Expands Mammography Services To Eligible Women In Their 40s, North Dakota, USA

Women"s Way, North Dakota"s breast and cervical cancer early detection program, is expanding its services to include screening mammograms for eligible women ages 40 through 49, according to Mary Ann Foss, Women"s Way program director for the North Dakota Department of Health. Previously, women ages 50 through 64 enrolled in Women"s Way were eligible to receive mammograms. As part of the Department of Health"s 2009-2011 budget, the 2009 Legislative Assembly included additional funding for Women"s Way, which allowed expansion of mammography services to women in their 40s. "We know that mammograms are a terrific screening tool for detecting abnormalities in the breast," Foss said. "Expanding our services to include mammograms for eligible women in their 40s will help us detect more cancers in their early stages when they can be treated more successfully. We are so pleased to be able to offer mammograms to more of our clients." "When it comes to breast cancer, studies show that effective screening can truly save lives," said First Lady Mikey Hoeven. "Expanding the program will mean earlier detection and, most importantly, earlier treatment for more women who need it." Women"s Way helps women who have limited incomes and do not have insurance that covers breast and cervical exams. Women who enroll in Women"s Way usually receive the screening services from the doctor or clinic they select. To find out if they are eligible, women can call 1- 800-44 WOMEN. The toll-free call will ring to the local public health office in their area. North Dakota Department of Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009